loading page…
loading page…
Full JRCPTB Respiratory Medicine curriculum coverage, BTS, ERS and GOLD guidance, candidate-reported pitfalls and an AI-adaptive question bank by UK chest physicians — grounded in asthma biologics, COPD optimisation, ILD pathways, lung cancer staging and sleep medicine.
Full SCE Respiratory Medicine bank, AI Tutor and timed mocks — $29/month or $99/year. All paid exam banks included.
100 best-of-five SBAs · 3 hours · computer-based at Pearson VUE designated test centres
100 best-of-five SBAs · 3 hours · same day, after a 1-hour break · imaging, PFTs, sleep traces
Pitched at the level of a doctor approaching CCT in respiratory medicine — imaging interpretation, biologic eligibility, ILD multidisciplinary workup
2026/01 sitting: 2 September 2026. Application window: 13 May–10 June 2026. Reasonable adjustment deadline: 18 June 2026. Results released approximately 6 weeks after the exam. From June 2026 sittings are delivered in centre.
Approximate question distribution across the JRCPTB Respiratory Medicine curriculum. Used to drive iatroX adaptive sequencing.
Source: official Federation of the Royal Colleges of Physicians of the UK blueprint
Drawn from the JRCPTB curriculum, BTS/GOLD/ERS guidelines and item density in iatroX.
COPD GOLD 2024/25 — Group A/B/E classification, LAMA-LABA-ICS triple therapy criteria (eosinophil-guided), exacerbation management with corticosteroids/antibiotics, NIV for hypercapnic respiratory failure
Asthma biologics per BTS/NICE — omalizumab (anti-IgE), mepolizumab/reslizumab/benralizumab (anti-IL-5/5R), dupilumab (anti-IL-4Rα), tezepelumab (anti-TSLP). Eligibility thresholds (eosinophils, FeNO, IgE level)
Lung cancer — TNM 9th edition (2024 update), reflex driver mutation testing (EGFR/ALK/ROS1/BRAF/RET/MET/KRAS/HER2), neoadjuvant chemo-IO (CheckMate 816), adjuvant osimertinib (ADAURA), small-cell limited and extensive disease IO + chemo
IPF and progressive pulmonary fibrosis — antifibrotic eligibility (FVC thresholds), CT-HRCT pattern recognition (UIP, NSIP, OP), CTD-ILD screening (anti-MDA5 in dermatomyositis, anti-Scl-70 in SSc), recent CHEST/ATS PPF guidance
Pulmonary embolism — ESC 2024 guidelines, intermediate-low vs intermediate-high vs high-risk PE, thrombolysis criteria, DOACs first-line for most, BTS PE outpatient management
OSA — STOP-BANG, AHI thresholds for CPAP, central vs obstructive apnoea, complex sleep apnoea on initiation. Hypoventilation syndromes (OHS, motor neurone disease, neuromuscular)
CFTR modulators — elexacaftor-tezacaftor-ivacaftor (ETI/Trikafta/Kaftrio), age and mutation eligibility, monitoring (LFTs, mental health), implications for transplant listing
Pleural disease BTS 2023 update — pneumothorax conservative management, malignant pleural effusion (IPC vs talc), septated empyema (intra-pleural tPA-DNase per MIST-2), mesothelioma staging
Observations from UK respiratory trainees and recent SCE candidates. Verify against current BTS, NICE and GOLD guidance.
Candidate-reported observations — not official guidance.
A pragmatic phased approach used by recent ST5–ST6 respiratory medicine passers.
A live item from the iatroX bank. Try it before launching a full session.
A 46-year-old pigeon breeder has episodic fever, cough and breathlessness that worsen after cleaning his loft. HRCT shows centrilobular ground-glass nodules, mosaic attenuation and air trapping on expiratory imaging. FVC is 78% predicted and TLCO is 52% predicted. What is the most likely diagnosis?
Why iatroX is built differently for SCE Respiratory Medicine.
Every iatroX item is tagged to a blueprint topic, so your performance dashboard mirrors the structure of the exam itself.
The engine surfaces your weakest topics first, in real time, instead of marching you through a static syllabus.
Incorrect items return at increasing intervals to interrupt the forgetting curve and lock knowledge into long-term memory.
Timed full-length simulations that mirror the official exam structure under realistic conditions.
One iatroX subscription includes the SCE Respiratory Medicine bank, the Socratic Tutor inside supported sessions, and every other premium iatroX exam bank.
Cancel anytime · 7-day money-back guarantee on annual
Over 1,000 best-of-five SBAs mapped to the published JRCPTB Respiratory Medicine curriculum and Federation blueprint, with substantial image-led HRCT and PFT content.
Once yearly in September. The 2026 sitting is on 2 September 2026. Applications open 13 May 2026 and close 10 June 2026. Results are released approximately 6 weeks after the exam.
Two papers of 100 best-of-five SBAs each, three hours per paper, sat on the same day with a one-hour break between. Total 200 questions. From June 2026 all sittings are in-centre at Pearson VUE locations. Paper 2 is widely reported to carry more image and PFT-style items.
Most UK trainees sit during ST5 or ST6 (penultimate year of higher specialty training). There are no formal restrictions on when in training you sit, but CCT requires a pass before completion. International candidates can sit at any time once registered with the Federation.
UK fee is £700; international fee is £875. Fees are non-refundable after the application closing date. From June 2026 all sittings are delivered in-centre at Pearson VUE locations.
Substantial. Paper 2 carries more imaging (HRCT, plain chest film, CT-PA), PFT traces, sleep studies and bronchoscopy findings. Dedicated image practice is essential — iatroX includes a respiratory image bank covering UIP/NSIP/OP HRCT patterns, PFTs and CT lung cancer staging.
Yes. A single iatroX subscription (£29/month or £99/year for UK users; $29/$99 elsewhere) includes the SCE Respiratory Medicine bank alongside every other premium iatroX exam bank. No add-ons or per-exam fees.
Other iatroX hubs you may find useful.
see how iatroX compares to PassMedicine, Quesmed.
Reviewed by Dr Kola Tytler MBBS CertHE MBA MSt MRCGP · Last reviewed 12 May 2026
See our methodology and editorial policy.